Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

X0202 SCHEDULE 13D/A 0001213900-21-050360 0001720215 XXXXXXXX LIVE 1 Class A Common Stock, par value $0.0001 per share 04/02/2026 false 0001812173 92561V208 Vicarious Surgical Inc. 78 Fourth Avenue Waltham MA 02451 Rebecca Lucia (650) 644-6822 c/o Innovation Endeavors 1845 El Camino Real Palo Alto CA 94306 0001720215 N Innovation Endeavors III LP b WC N E9 0.00 221038.00 0.00 221038.00 221038.00 N 3.4 PN 0001883780 N Dror Berman b AF N X1 0.00 221038.00 0.00 221038.00 221038.00 N 3.4 HC IN Class A Common Stock, par value $0.0001 per share Vicarious Surgical Inc. 78 Fourth Avenue Waltham MA 02451 This Amendment No. 1 (this "Amendment No. 1" or this "Schedule 13D/A") amends and supplements the statement on Schedule 13D originally filed with the Securities and Exchange Commission (the "SEC") on September 28, 2021 (the "Statement") by the Reporting Persons. Unless otherwise defined herein, capitalized terms used in this Amendment No. 1 shall have the meanings ascribed to them in the Statement. Unless amended or supplemented below, the information in the Statement remains unchanged. Rows 11 and 13 of each Reporting Person's cover page to this Schedule 13D set forth the aggregate number of shares of Class A common stock and percentages of the shares of Class A common stock beneficially owned by such Reporting Person and are incorporated by reference. The percentage set forth in each row 13 is based upon 6,470,228 shares of Class A common stock outstanding as of March 16, 2026, as reported in the Issuer's definitive proxy statement, filed with the SEC on March 23, 2026. The Reporting Persons' beneficial ownership of the Issuer's securities includes 221,038 shares of Class A common stock directly held by Innovation Endeavors. Mr. Berman is a managing partner at Innovation Endeavors and shares voting and investment authority over the shares held by Innovation Endeavors. Rows 7 through 10 of each Reporting Person's cover page to this Schedule 13D set forth the number of shares of Class A common stock as to which such Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition and are incorporated by reference. Except as set forth below, none of the Reporting Persons has effected any transactions with respect to the securities of the Issuer during the past sixty days. On March 20, 2026, Innovation Endeavors sold an aggregate of 10,774 shares in open market transactions at prices ranging from $1.05 to $1.11 (weighted average sales price of $1.06 per share). On March 23, 2026, Innovation Endeavors sold an aggregate of 25,000 shares in open market transactions at prices ranging from $1.00 to $1.05 (weighted average sales price of $1.00 per share). On March 24, 2026, Innovation Endeavors sold an aggregate of 1,001 shares in open market transactions at prices ranging from $0.95 to $1.00 (weighted average sales price of $0.95 per share). On March 25, 2026, Innovation Endeavors sold an aggregate of 25 shares in an open market transaction at a price of $1.00 per share. On March 26, 2026, Innovation Endeavors sold an aggregate of 3,013 shares in open market transactions at prices ranging from $0.85 to $1.00 (weighted average sales price of $0.91 per share). On March 27, 2026, Innovation Endeavors sold an aggregate of 1,000 shares in open market transactions at prices ranging from $0.70 to $0.72 (weighted average sales price of $0.70 per share). On March 30, 2026, Innovation Endeavors sold an aggregate of 4,595 shares in open market transactions at prices ranging from $0.80 to $0.81 (weighted average sales price of $0.80 per share). On March 31, 2026, Innovation Endeavors sold an aggregate of 1,449 shares in open market transactions at prices ranging from $0.71 to $0.83 (weighted average sales price of $0.76 per share). On April 1, 2026, Innovation Endeavors sold an aggregate of 1,487 shares in open market transactions at prices ranging from $0.65 to $0.88 (weighted average sales price of $0.80 per share). On April 2, 2026, Innovation Endeavors sold an aggregate of 53,868 shares in open market transactions at prices ranging from $0.72 to $0.83 (weighted average sales price of $0.78 per share). On April 6, 2026, Innovation Endeavors sold an aggregate of 136,682 shares in open market transactions at prices ranging from $0.78 to $0.85 (weighted average sales price of $0.82 per share). No other person is known to have the right to receive or the power to direct the receipt of dividends from, or any proceeds from the sale of, the securities beneficially owned by any of the Reporting Persons. The Reporting Persons ceased to be the beneficial owners of more than five percent of the Class A common stock on April 6, 2026. Exhibit 99.1 Joint Filing Agreement (incorporated by reference to Exhibit 1 to the Reporting Persons' Schedule 13D filed with the SEC on September 28, 2021). Innovation Endeavors III LP /s/ Dror Berman By Dror Berman, Managing Partner 04/06/2026 Dror Berman /s/ Dror Berman Dror Berman 04/06/2026